"Female Viagra" seen more a pace-setter than moneymaker

Aug 19 (Reuters) - The first U.S. treatment for low sexual desire in women, dubbed "female Viagra," is more likely to help build a market for better future rival drugs than achieve the sales seen for Pfizer Inc's famous little blue pill for men, industry experts said.